PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Cancer Research, London, UK abhijit.pal@sydney.edu.au.\', \'Drug Development Unit, Royal Marsden Hospital Sutton, London, UK.\', \'The University of Sydney, Sydney, New South Wales, Australia.\', \'Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.\', \'Clinical Trials and Statistics Unit, Institute of Cancer Research, London, UK.\', \'Institute of Cancer Research, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmjopen-2021-049217
?:doi
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 34489282
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
?:title
  • Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all